Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer

Area of Science:

• Oncology
• Cancer Metastasis Research
• Molecular Biology

Background:

• Breast cancer is the most common malignancy in women, with approximately 30% of patients developing metastasis annually.
• Liver metastasis significantly increases breast cancer mortality, with bone, brain, liver, and lung as primary metastatic sites.
• The precise molecular mechanisms driving breast cancer liver metastasis (BCLM) remain incompletely understood.

Purpose of the Study:

• To review and summarize the current understanding of the molecular mechanisms underlying breast cancer liver metastasis (BCLM).
• To provide an overview of emerging and established treatment strategies for BCLM.
• To highlight the importance of clarifying BCLM mechanisms for guiding clinical interventions.

Main Methods:

• Literature review of existing studies on breast cancer metastasis to the liver.
• Analysis of molecular signaling pathways implicated in BCLM.
• Summary of current and novel therapeutic approaches for BCLM.

Main Results:

• BCLM is a complex process influenced by primary tumor and liver microenvironments, as well as various signaling pathways.
• Recent advancements in targeted and endocrine therapies offer new avenues for BCLM treatment.
• Clarification of molecular drivers is essential for optimizing clinical management.

Conclusions:

• Further research into the intricate mechanisms of BCLM is vital for improving patient outcomes.
• Targeted therapies and endocrine treatments represent promising strategies for managing BCLM.
• A comprehensive understanding of BCLM pathogenesis will guide the development of more effective clinical treatments.